Alife Health Partners with Hamilton Thorne for IVF Innovation
Alife Health and Hamilton Thorne, Inc. have embarked on an exciting partnership to enhance access to sophisticated AI solutions that support clinical decision-making in the IVF process. This collaboration is set to harness the expertise of both companies to improve outcomes for those seeking to grow their families.
What the Partnership Offers
The partnership will enable Alife's Embryo Assist software to be integrated into Hamilton Thorne's precision laser systems. This integration will allow embryologists to create detailed digital records for each embryo, utilizing Alife's Clinical Decision Support (CDS) algorithm. This powerful tool helps clinicians determine the optimal embryo for transfer, enhancing the overall chance of a successful pregnancy.
Embryo Assist: A Game-Changer for Embryologists
The Embryo Assist software is a microscope-integrated application that simplifies the process of capturing images and data of embryos, thereby elevating laboratory quality control. Its unique AI ranking feature uses machine learning to identify which embryos have the highest potential for success, aiding embryologists in their critical work. This innovative technology received accolades in a scientific abstract, showing its performance to be comparable to that of seasoned embryologists in manual grading.
Quotes from Leadership
Catherine Welch, VP of Clinical Sales & Customer Success (Americas) for Hamilton Thorne, expressed the company’s commitment to enhancing their product suite through collaborations with innovative partners. "We prioritize partnerships with forward-thinking companies to drive customer-centric solutions that bring innovations to life," she stated.
Melissa Teran, COO and Head of Product for Alife Health, shared her enthusiasm for the partnership, emphasizing the mutual goal of leveraging technology to improve care for individuals seeking to expand their families. This partnership not only marks a significant leap forward for both organizations but also for the IVF community at large.
Alife's Mission and Vision
Alife Health's vision is to revolutionize the IVF journey. By applying advanced artificial intelligence, the company is committed to personalizing and modernizing this crucial process, ultimately improving patient care. They have established partnerships with esteemed clinics and top-tier physicians, ensuring significant advancements in clinical outcomes for patients worldwide.
About Hamilton Thorne, Inc.
Hamilton Thorne Inc. specializes in providing innovative solutions for the fertility industry. With over three decades of experience, the company has evolved from serving the animal breeding market to becoming a key player in the field of Assisted Reproductive Technologies and Developmental Biology. Their extensive product range includes precision laser systems, CASA systems, and other essential tools that support IVF professionals globally.
Contact Information
For inquiries, Alife Health can be reached through Jamie Gray. Hamilton Thorne’s representative is Catherine Welch, who is available for questions pertaining to this strategic partnership.
Frequently Asked Questions
What does the partnership between Alife Health and Hamilton Thorne entail?
The partnership focuses on integrating Alife's Embryo Assist software with Hamilton Thorne's laser systems to enhance clinical decision-making in IVF.
How does the Embryo Assist software help embryologists?
It allows embryologists to capture images and data easily while utilizing an AI ranking system to identify embryos most likely to succeed.
What is Alife Health's primary mission?
Alife Health aims to personalize and modernize the IVF process using advanced AI technology to improve patient outcomes.
How long is the trial period for Hamilton Thorne clients?
All US-based clients will receive a three-month trial of the Embryo Assist technology as part of the partnership.
What are the main products offered by Hamilton Thorne?
Hamilton Thorne offers precision laser systems, imaging systems, and CASA systems aimed at advancing assisted reproductive technologies.
